Last updated: 22 July 2019 at 2:40pm EST

James H Welch Net Worth




The estimated Net Worth of James H Welch is at least $235 Thousand dollars as of 20 June 2016. James Welch owns over 2,500 units of Rigel Pharmaceuticals stock worth over $32,425 and over the last 21 years James sold RIGL stock worth over $202,300.

James Welch RIGL stock SEC Form 4 insiders trading

James has made over 3 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently James bought 2,500 units of RIGL stock worth $49,500 on 20 June 2016.

The largest trade James's ever made was buying 10,000 units of Rigel Pharmaceuticals stock on 6 September 2011 worth over $33,400. On average, James trades about 1,184 units every 227 days since 2003. As of 20 June 2016 James still owns at least 2,500 units of Rigel Pharmaceuticals stock.

You can see the complete history of James Welch stock trades at the bottom of the page.



What's James Welch's mailing address?

James's mailing address filed with the SEC is , , , , .

Insiders trading at Rigel Pharmaceuticals

Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.



What does Rigel Pharmaceuticals do?

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.



Complete history of James Welch stock trades at Acelrx Pharmaceuticals Inc, Aduro BioTech, Eiger BioPharmaceuticals Inc, and Rigel Pharmaceuticals

Insider
Trans.
Transaction
Total value
James H Welch
Chief Financial Officer
Buy $49,500
20 Jun 2016
James H Welch
Chief Financial Officer
Buy $33,400
6 Sep 2011
James H Welch
Vice President, CFO, and Corp Secretary
Sale $202,300
2 Sep 2004


Rigel Pharmaceuticals executives and stock owners

Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: